Program to calm ICU patients and reduce restraints
Part of Brain & nervous system clinical trials.
This study tests a multi-step program to prevent and lessen agitation in ICU patients, with the goal of reducing the need for physical restraints. It also aims to improve comfort and safety during a longer ICU stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- Your ICU stay is expected to last more than 24 hours.
- You are likely to become agitated (restless, confused, or upset) within the first 14 days in the ICU.
- You can be considered for a specific calming medicine (dexmedetomidine), without key heart-blood-pressure or allergy problems.
- You are not on ECMO (a heart-lung machine).
- You have not joined another sedation study, and consent is available for long-term follow-up in MONITOR-IC.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called dexmedetomidine (a sedative) can help calm patients with severe brain injury who are on a breathing machine in the intensive care unit. If you or your loved one is in this situation, this treatment might reduce agitation and improve recovery.
This trial tests two different medications to quickly calm severe agitation in people admitted to a psychiatric emergency room. You may be able to join if you are extremely agitated and need urgent medication to help you settle down.
This trial uses a special camera to monitor ICU patients who may become agitated. By watching your face and body movements, doctors hope to detect agitation early and improve your care.
This study tests two medications, haloperidol and dexmedetomidine, to see which works better for reducing confusion and agitation in patients who are on a breathing machine after a traumatic brain injury. If you or a loved one is in the ICU with a brain injury and is restless or confused, this trial may help find better ways to manage those symptoms.
This study tests whether giving a medicine called dexmedetomidine (which helps people relax and sleep) as part of a sleep-promoting routine can reduce confusion and delirium in the intensive care unit (ICU). It may help you sleep better and recover more smoothly.
This trial tests a new sedation protocol for adults in intensive care who need strong pain relief or sedation medicines. It aims to make sedation safer and more comfortable, and includes people on ECMO (a heart-lung machine) or a ventilator (breathing machine) for severe breathing problems.
Hear when a new Agitation,Psychomotor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.